MARC HOROWITZ

Concepts (284)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Antineoplastic Combined Chemotherapy Protocols
30
2006
1227
0.680
Why?
Brain Neoplasms
24
2013
1232
0.660
Why?
Sarcoma
11
1998
195
0.470
Why?
Survivors
3
2022
344
0.460
Why?
Bone Neoplasms
11
1996
427
0.460
Why?
Sarcoma, Ewing
10
1996
113
0.450
Why?
Soft Tissue Neoplasms
8
1996
130
0.400
Why?
Ependymoma
8
2013
133
0.310
Why?
Cyclophosphamide
6
2005
419
0.300
Why?
Neoplasms
8
2022
2758
0.280
Why?
Rhabdomyosarcoma
10
1996
200
0.260
Why?
Antineoplastic Agents
7
2013
1661
0.250
Why?
Neoplasms, Germ Cell and Embryonal
3
2005
88
0.240
Why?
Work Schedule Tolerance
1
2003
38
0.220
Why?
Child, Preschool
38
2014
13888
0.200
Why?
Burnout, Professional
1
2003
114
0.190
Why?
Combined Modality Therapy
21
1999
1240
0.190
Why?
Doxorubicin
5
1996
299
0.180
Why?
Decision Support Systems, Clinical
1
2022
170
0.180
Why?
Internet
2
2022
378
0.160
Why?
Stress, Psychological
1
2003
557
0.160
Why?
Thiotepa
2
1995
15
0.150
Why?
Kidney Tubules
6
1987
82
0.150
Why?
Thrombocytopenia
2
1996
228
0.140
Why?
Child
37
2022
24244
0.130
Why?
Agranulocytosis
1
1996
14
0.130
Why?
Razoxane
1
1996
10
0.130
Why?
Granulocyte-Macrophage Colony-Stimulating Factor
1
1996
66
0.130
Why?
Cisplatin
5
1995
242
0.120
Why?
Antibiotics, Antineoplastic
1
1996
126
0.120
Why?
Cardiovascular Agents
1
1996
86
0.120
Why?
Infant
25
2013
12347
0.120
Why?
Cancer Survivors
1
2018
197
0.120
Why?
Medulloblastoma
5
2013
338
0.110
Why?
Ifosfamide
6
1996
36
0.110
Why?
Whole-Body Irradiation
1
1993
65
0.110
Why?
Humans
63
2022
123213
0.110
Why?
Education, Medical, Graduate
2
2010
507
0.100
Why?
Neuroectodermal Tumors, Primitive, Peripheral
4
1996
18
0.100
Why?
Adolescent
29
2006
19124
0.100
Why?
Glioma
8
2006
496
0.100
Why?
Bone Marrow Transplantation
2
1999
577
0.100
Why?
Lung Neoplasms
4
1998
1582
0.100
Why?
Male
36
2013
60117
0.090
Why?
Heart
1
1996
722
0.090
Why?
Neoplasms, Second Primary
3
1998
151
0.090
Why?
Adult
26
2006
29091
0.090
Why?
Female
35
2013
65516
0.080
Why?
Schools, Medical
1
2010
113
0.080
Why?
Survival Analysis
8
2006
1472
0.080
Why?
Disease-Free Survival
4
2006
861
0.070
Why?
Leadership
1
2010
227
0.070
Why?
Pilot Projects
4
1999
1388
0.070
Why?
Osteosarcoma
6
1995
257
0.070
Why?
Rhabdoid Tumor
2
1997
49
0.070
Why?
Glioblastoma
3
1996
334
0.070
Why?
Etoposide
3
1996
117
0.070
Why?
Vincristine
3
1996
195
0.070
Why?
Drug Administration Schedule
6
1998
729
0.060
Why?
Injections, Spinal
1
2005
117
0.060
Why?
Maximum Tolerated Dose
1
2005
157
0.060
Why?
Morphine
1
2005
87
0.060
Why?
Chromosome Aberrations
3
1995
614
0.060
Why?
Headache
1
2005
108
0.060
Why?
Switzerland
1
2003
18
0.060
Why?
Affect
1
2005
155
0.060
Why?
Misonidazole
1
1983
2
0.060
Why?
Radiotherapy, Adjuvant
3
1999
142
0.050
Why?
Survival Rate
7
1999
1997
0.050
Why?
Dexamethasone
1
2005
272
0.050
Why?
Nitroimidazoles
1
1983
52
0.050
Why?
Workload
1
2003
146
0.050
Why?
Survivorship
1
2022
36
0.050
Why?
Glucocorticoids
1
2005
378
0.050
Why?
Pain
1
2005
470
0.050
Why?
Carrier Proteins
4
2006
1019
0.050
Why?
Analgesics, Opioid
1
2005
402
0.040
Why?
Follow-Up Studies
8
1998
5047
0.040
Why?
Mesna
3
1989
10
0.040
Why?
Pinealoma
2
1999
19
0.040
Why?
Radiotherapy Dosage
4
1996
185
0.040
Why?
Cranial Irradiation
2
1999
69
0.040
Why?
Neurilemmoma
4
1993
46
0.040
Why?
Mercaptoethanol
2
1989
6
0.040
Why?
Kidney Diseases
3
1987
478
0.040
Why?
Age Factors
1
2005
2802
0.040
Why?
Prognosis
8
1998
4507
0.040
Why?
Liver Neoplasms
2
1987
1308
0.040
Why?
Patient Care Planning
1
2018
123
0.030
Why?
Prospective Studies
5
1996
6033
0.030
Why?
Acetylglucosaminidase
5
1987
17
0.030
Why?
Neoplasms, Radiation-Induced
1
1996
81
0.030
Why?
Camptothecin
1
1996
76
0.030
Why?
Postoperative Period
3
1998
330
0.030
Why?
Transaminases
1
1996
32
0.030
Why?
Neoplasms, Experimental
4
1983
211
0.030
Why?
Injections, Intravenous
1
1996
252
0.030
Why?
Astrocytoma
3
1993
103
0.030
Why?
Pineal Gland
1
1995
17
0.030
Why?
Hematopoiesis, Extramedullary
1
1995
9
0.030
Why?
Choroid Plexus Neoplasms
1
1995
14
0.030
Why?
Guideline Adherence
1
2018
375
0.030
Why?
Karyotyping
3
1995
330
0.030
Why?
Thymus Gland
1
1995
99
0.030
Why?
Neutropenia
1
1996
202
0.030
Why?
Aminopeptidases
4
1987
19
0.030
Why?
CD13 Antigens
4
1987
15
0.030
Why?
Drug Evaluation
6
1992
111
0.030
Why?
Lymphocyte Depletion
1
1994
123
0.030
Why?
L-Lactate Dehydrogenase
2
1991
62
0.030
Why?
Ganglioglioma
1
1994
24
0.030
Why?
Tomography, X-Ray Computed
3
1993
2049
0.030
Why?
Foot
1
1994
63
0.030
Why?
Pneumonectomy
1
1995
129
0.030
Why?
Proteinuria
4
1987
110
0.030
Why?
Stroke Volume
1
1996
445
0.030
Why?
Nevus, Pigmented
1
1993
32
0.030
Why?
Nitrosourea Compounds
2
1983
4
0.030
Why?
Ethylnitrosourea
2
1983
11
0.030
Why?
Retroperitoneal Neoplasms
1
1993
31
0.030
Why?
Hand
1
1994
102
0.030
Why?
Supratentorial Neoplasms
1
2013
37
0.030
Why?
Internship and Residency
1
2003
1158
0.030
Why?
Treatment Outcome
5
2013
12134
0.030
Why?
Neoplasm Proteins
2
1994
669
0.030
Why?
Cholecystokinin
1
1992
14
0.030
Why?
Blood-Brain Barrier
2
1983
141
0.030
Why?
Carcinoma
1
1995
278
0.030
Why?
Pentetic Acid
1
1992
10
0.020
Why?
Topotecan
2
2006
49
0.020
Why?
Meglumine
1
1992
15
0.020
Why?
Gadolinium DTPA
1
1992
48
0.020
Why?
Membrane Glycoproteins
1
1994
414
0.020
Why?
CD4-Positive T-Lymphocytes
1
1995
473
0.020
Why?
Cerebrovascular Circulation
3
1983
434
0.020
Why?
Organometallic Compounds
1
1992
106
0.020
Why?
Osteotomy
1
1991
39
0.020
Why?
Extremities
1
1991
82
0.020
Why?
Hot Temperature
1
1971
136
0.020
Why?
Thoracotomy
1
1992
108
0.020
Why?
Drug Combinations
1
1992
271
0.020
Why?
Practice Guidelines as Topic
1
2018
1262
0.020
Why?
Neoplasm Recurrence, Local
2
1993
1117
0.020
Why?
Central Nervous System Neoplasms
1
1992
194
0.020
Why?
Professional Competence
1
2010
97
0.020
Why?
Methotrexate
2
1990
341
0.020
Why?
Heart Rate
1
1971
587
0.020
Why?
Contrast Media
1
1992
467
0.020
Why?
Aging
1
1995
1174
0.020
Why?
Fibroma
1
1987
30
0.020
Why?
Hospitalization
1
1996
1736
0.020
Why?
Creatinine
2
1987
380
0.020
Why?
Clinical Trials as Topic
2
1996
1088
0.020
Why?
Thymectomy
1
1987
19
0.020
Why?
Organoplatinum Compounds
1
1987
29
0.020
Why?
Infant, Newborn
3
1999
8107
0.020
Why?
Autoradiography
2
1983
71
0.020
Why?
Blood
1
1987
105
0.020
Why?
Sensitivity and Specificity
1
1992
2022
0.020
Why?
Neuroectodermal Tumors, Primitive
2
1999
52
0.020
Why?
Rats, Inbred F344
2
1983
105
0.020
Why?
Neoplasm Metastasis
2
1986
650
0.020
Why?
Skin Neoplasms
1
1993
795
0.020
Why?
Mice, Inbred Strains
1
1987
311
0.020
Why?
Procarbazine
1
2006
13
0.020
Why?
Microscopy, Electron
1
1987
391
0.020
Why?
MutS Homolog 2 Protein
1
2006
37
0.020
Why?
Magnetic Resonance Imaging
3
1993
3540
0.020
Why?
Nervous System
1
1987
128
0.020
Why?
Alkyl and Aryl Transferases
1
2006
18
0.020
Why?
MutL Protein Homolog 1
1
2006
54
0.020
Why?
Neoplasm Transplantation
1
1987
369
0.020
Why?
Regional Blood Flow
2
1983
213
0.020
Why?
DNA, Neoplasm
1
1987
300
0.020
Why?
Tissue Distribution
2
1983
382
0.020
Why?
Chemotherapy, Adjuvant
2
1999
354
0.020
Why?
Chromosomes, Human, 1-3
1
1985
2
0.020
Why?
Dose-Response Relationship, Drug
3
1995
1683
0.020
Why?
Child Development
1
1988
261
0.020
Why?
Neoplasm, Residual
1
2006
121
0.020
Why?
Preoperative Care
1
1987
350
0.020
Why?
Cell Division
1
1987
780
0.020
Why?
Rats
4
1983
3654
0.010
Why?
Gene Expression Regulation, Neoplastic
1
1992
1870
0.010
Why?
Flow Cytometry
1
1987
803
0.010
Why?
Anti-Bacterial Agents
1
1996
2396
0.010
Why?
Lung
1
1992
1475
0.010
Why?
Neoplasm Staging
3
1994
1213
0.010
Why?
Treatment Failure
2
1995
338
0.010
Why?
Heart Failure
1
1996
2127
0.010
Why?
Proportional Hazards Models
2
1998
1305
0.010
Why?
Adaptor Proteins, Signal Transducing
1
2006
531
0.010
Why?
Infusions, Intravenous
2
1996
536
0.010
Why?
Immunohistochemistry
1
2006
1687
0.010
Why?
Life Tables
2
1991
29
0.010
Why?
Tumor Cells, Cultured
2
1992
1063
0.010
Why?
Retrospective Studies
3
2010
16019
0.010
Why?
Nuclear Proteins
1
2006
1266
0.010
Why?
Recurrence
2
1994
1422
0.010
Why?
Aneuploidy
2
1992
152
0.010
Why?
Fluorouracil
2
1990
128
0.010
Why?
Multicenter Studies as Topic
1
1999
263
0.010
Why?
Drug Synergism
2
1990
239
0.010
Why?
Animals
5
1987
33761
0.010
Why?
Salvage Therapy
1
1999
193
0.010
Why?
Growth Disorders
1
1999
207
0.010
Why?
Incidence
2
1996
3047
0.010
Why?
Age Distribution
1
1998
410
0.010
Why?
Time Factors
3
1994
6217
0.010
Why?
Dipeptidyl Peptidase 4
2
1986
22
0.010
Why?
Dose-Response Relationship, Radiation
1
1996
66
0.010
Why?
Fatal Outcome
1
1997
356
0.010
Why?
Dacarbazine
2
1987
86
0.010
Why?
Brain Stem
1
1996
115
0.010
Why?
Reoperation
1
1998
819
0.010
Why?
Leukocyte Common Antigens
1
1995
90
0.010
Why?
Lymphocyte Count
1
1994
114
0.010
Why?
CD4 Lymphocyte Count
1
1995
230
0.010
Why?
Risk
1
1996
747
0.010
Why?
Gliosarcoma
1
1994
11
0.010
Why?
Fibrosarcoma
1
1994
28
0.010
Why?
Opportunistic Infections
1
1994
79
0.010
Why?
Rhabdomyosarcoma, Alveolar
1
1994
37
0.010
Why?
Immunoenzyme Techniques
1
1994
262
0.010
Why?
Glial Fibrillary Acidic Protein
1
1994
104
0.010
Why?
Immunophenotyping
1
1994
330
0.010
Why?
Oligodendroglioma
2
1983
24
0.010
Why?
Aminoisobutyric Acids
2
1983
9
0.010
Why?
Drug Resistance
1
1994
256
0.010
Why?
Rats, Inbred Strains
2
1983
229
0.010
Why?
Craniotomy
1
1994
108
0.010
Why?
Mitosis
1
1994
238
0.010
Why?
Lymphoma, Non-Hodgkin
1
1995
162
0.010
Why?
Chromosomes, Human, Pair 13
1
1992
50
0.010
Why?
Meningioma
1
1994
120
0.010
Why?
Myelography
1
1992
9
0.010
Why?
Meningeal Neoplasms
1
1994
183
0.010
Why?
Molecular Weight
1
1992
392
0.010
Why?
RNA, Neoplasm
1
1992
138
0.010
Why?
Oncogenes
1
1992
168
0.010
Why?
Skin Temperature
1
1971
19
0.010
Why?
Neoplasm Invasiveness
1
1993
602
0.010
Why?
Meta-Analysis as Topic
1
1991
153
0.010
Why?
In Vitro Techniques
1
1992
966
0.010
Why?
Fetal Heart
1
1971
111
0.010
Why?
Leucovorin
1
1990
50
0.010
Why?
Cerebellar Neoplasms
1
1993
282
0.010
Why?
Mice
1
1987
17496
0.010
Why?
Regression Analysis
1
1991
773
0.010
Why?
Chromosome Mapping
1
1992
1081
0.010
Why?
Predictive Value of Tests
1
1995
2108
0.010
Why?
Chromatography, High Pressure Liquid
1
1990
338
0.010
Why?
Risk Assessment
1
1998
3328
0.010
Why?
Remission Induction
1
1989
300
0.000
Why?
Dactinomycin
1
1987
67
0.000
Why?
Brain
2
1994
2962
0.000
Why?
Immunochemistry
1
1986
30
0.000
Why?
Saline Solution, Hypertonic
1
1987
20
0.000
Why?
Carboplatin
1
1987
75
0.000
Why?
Osmolar Concentration
1
1986
174
0.000
Why?
Urologic Diseases
1
1987
44
0.000
Why?
Biomarkers, Tumor
1
1994
1430
0.000
Why?
Hematologic Diseases
1
1987
78
0.000
Why?
RNA, Messenger
1
1992
2815
0.000
Why?
Embryonal Carcinoma Stem Cells
1
1985
10
0.000
Why?
Clone Cells
1
1985
163
0.000
Why?
Wilms Tumor
1
1985
112
0.000
Why?
Lymphoma
1
1987
321
0.000
Why?
Acute Disease
1
1987
1092
0.000
Why?
Methylnitrosourea
1
1983
19
0.000
Why?
Choroid Plexus
1
1983
23
0.000
Why?
Subarachnoid Space
1
1983
24
0.000
Why?
Capillary Permeability
1
1983
78
0.000
Why?
Neoplastic Stem Cells
1
1985
294
0.000
Why?
Nervous System Diseases
1
1987
372
0.000
Why?
Biological Transport
1
1983
347
0.000
Why?
Head and Neck Neoplasms
1
1987
481
0.000
Why?
Chromosome Deletion
1
1985
638
0.000
Why?
Blood Flow Velocity
1
1983
449
0.000
Why?
Kinetics
1
1983
1314
0.000
Why?
Pregnancy
2
1983
7147
0.000
Why?
Hippocampus
1
1983
820
0.000
Why?
Carcinoma, Hepatocellular
1
1985
935
0.000
Why?
Middle Aged
1
1994
26009
0.000
Why?
HOROWITZ's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (284)
Explore
_
Co-Authors (10)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_